Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. FSPHX: which is better?

Bottom line

PRHSX vs FSPHX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and FSPHX (Health Care Portfolio) share a meaningful slice of their top holdings — about 49% by weight.

FSPHX is cheaper at 0.62% vs 0.83% — a difference of $21 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +4.0% for FSPHX (reporting dates differ).

Updated Nov 19, 2026

PRHSX vs FSPHX side by side

PRHSXFSPHX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.62%
Annual cost per $10k$83$62
10-yr cost on $10k (prospectus)$1,025$774
Max front load——
12b-1 fee—0%
1-yr return+17.7%+14.4%
5-yr return (annualized)+4.2%+4.0%
10-yr return (annualized)+9.1%+9.0%
Best quarter+23.5%+22.2%
Worst quarter−15.8%−15.0%
Net assets (fund)$11.9B$5.8B
Number of holdings279152
Portfolio turnover62%69%
Returns as ofDec 31, 2025Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXFSPHXDifference
2025+17.7%+14.4%+3.3%
2024+1.8%+4.9%−3.1%
2023+3.1%+4.1%−1.1%
2022−12.2%−12.8%+0.6%
2021+13.3%+11.5%+1.8%
2020+30.1%+24.4%+5.7%
2019+29.1%+31.5%−2.3%
2018+1.2%+7.4%−6.2%
2017+28.0%+24.0%+3.9%
2016−10.4%−10.7%+0.3%

Source: Fund prospectus bar charts

Holdings overlap

12 of PRHSX's top 25 holdings also appear in FSPHX's top 25.

Shared top holdings
HoldingPRHSXFSPHX
Eli Lilly & Co14.28%8.03%
Johnson & Johnson6.63%4.91%
Unitedhealth Group Inc5.99%3.49%
Abbvie Inc5.10%2.03%
Merck & Co. Inc.4.01%1.60%
Gilead Sciences Inc2.82%2.21%
Thermo Fisher Scientific Inc2.52%4.33%
Natera Inc1.44%1.27%
Danaher Corp1.43%6.89%
Cvs Health Corp0.94%1.29%
Moderna Therapeutics Inc0.83%1.18%
Brightspring Health Services0.82%1.23%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FSPHX top 10

  1. ELI LILLY and CO — 8.03%
  2. Danaher Corp — 6.89%
  3. JOHNSON and JOHNSON — 4.91%
  4. Thermo Fisher Scientific Inc — 4.33%
  5. Unitedhealth Group Inc — 3.49%
  6. Alnylam Pharmaceuticals Inc — 2.40%
  7. Gilead Sciences Inc — 2.21%
  8. Boston Scientific Corp — 2.17%
  9. Ascendis Pharma A/s — 2.17%
  10. Fidelity Revere Street Trust — 2.17%

FAQ

What is the difference between PRHSX and FSPHX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and FSPHX (Health Care Portfolio) share a meaningful slice of their top holdings — about 49% by weight. FSPHX is cheaper at 0.62% vs 0.83% — a difference of $21 a year per $10,000 invested.
Which is cheaper, PRHSX or FSPHX?
FSPHX has the lower expense ratio (0.62%).
Should I own both PRHSX and FSPHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.